Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.

Image information can be used to predict the molecular classification of patient tumour samples in colour, using state-of-the-art deep learning models in pathology

Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.

Walden D. et al, (2026), JCO Precis Oncol, 10

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial.

Sushentsev N. et al, (2026), BJU Int

Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.

Chamba C. et al, (2026), Nat Med

Supplementary Figure S2 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S3 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S4 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S5 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S6 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Data from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S1 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

HIF-1-regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancer.

Zhou C. et al, (2026), NPJ Breast Cancer

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.

Beernaert B. et al, (2026), Sci Adv, 12

Lipid-rich ascites reprograms T cell lipid metabolic transcriptome to drive dysfunction

Wan PK-T. et al, (2026)

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Parker H. et al, (2026), Leukemia

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

Phyu SM. et al, (2026), Curr Opin Cell Biol, 99

A hierarchy of causes of death in senescent C. elegans

Wang H. et al, (2026), npj Aging

ISDE guidelines on the management of cT2N0 esophageal cancer.

Kohn GP. et al, (2026), Dis Esophagus, 39

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.

Duan Y. et al, (2026), JCO Precis Oncol, 10

HLA Heterozygosity Influences Colorectal Cancer Risk and Survival Outcome.

Tsai Y-Y. et al, (2026), Gastroenterology, 170, 619 - 622

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

Leonhardt C-S. et al, (2026), Lancet Oncol, 27, e141 - e149

Load More